FDG-PET/CT对隐源性缺血性卒中患者隐匿性癌检出率的研究
前瞻性观察性研究纳入140例隐源性缺血性卒中患者,均行全身FDG-PET/CT扫描。PET显示30%患者存在异常,最终确诊癌症者占18%。D-二聚体升高和较高的OCCULT-5评分与隐匿性癌相关。
要点
- 140例隐源性缺血性卒中患者行全身FDG-PET/CT,18%确诊隐匿性癌。
- PET扫描异常者占30%,最终确诊癌症者占18%。
- D-二聚体升高和较高OCCULT-5评分与隐匿性癌相关。
核心结论
- 本研究中18%的隐源性卒中病例经全身FDG-PET/CT扫描发现隐匿性癌,具有显著的治疗和预后意义。
- 部分影像学和实验室检测似乎有潜力用于筛选适合更advanced检查的患者。
研究设计与样本
- 前瞻性观察性研究,纳入接受FDG-PET/CT扫描的隐源性缺血性卒中患者,共140例,平均年龄71岁。
- 同时收集临床、影像学(三供血区征)和特定实验室检测(D-二聚体)信息。
主要发现
- 140例患者中,PET扫描显示30%存在异常,最终确诊癌症者占18%。
- D-二聚体水平升高和较高的OCCULT-5评分与隐匿性癌相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Cryptogenic stroke represents a third of ischemic strokes and has a significant recurrence rate. Occult cancer has been Identified as a causal factor in up to 5-10% of this type of strokes. We propose that a whole body FDG-PET/CT may increase the detection rate of occult cancer diagnosis in patients with cryptogenic stroke. PATIENTS AND METHODS: Observational prospective study including patients with cryptogenic ischemic stroke who underwent an FDG-PET/CT scan. Clinical, radiological (three territory sign) and specific analytical measurements (D-dimer) were also informed. RESULTS: A total of 140 patients were included in the study, with a mean age of 71. The PET scan showed abnormalities in 30% of patients with cryptogenic stroke, with a confirmed cancer diagnosis in 18%. Elevated D-dimer levels and a higher OCCULT-5 score were associated with occult cancer. CONCLUSIONS: Occult cancer was found in 18% of cryptogenic stroke cases in our study, evidenced by whole body FDF-PET/CT scans, which results in significant therapeutic and prognostic implications. Some imaging and analytical determinations seem to have potential for the selection of eligible patients for more advanced examinations.
引用
- García-Cabo C, Benavente L, Del Amor B, et al. Detection rate of FDG-PET/CT for occult cancer in patients with cryptogenic ischemic stroke. Eur J Nucl Med Mol Imaging. 2025. PMID: 40944722. doi:10.1007/s00259-025-07558-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。